Clinical Trials Browser

Phase 2 × SCLC, Extensive Stage × 90 days × Clear all

NCT06812260 2026-05-20

A Single-arm, Open-label, Phase II Study to Evaluate Efficacy, Safety and Pharmacokinetics of HLX10 + Chemotherapy in Patients With ES-SCLC

Phase 2 Active not recruiting

SCLC, Extensive Stage